CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $16,000 | +23.1% | 52,296 | +31.4% | 0.00% | – |
| Q3 2019 | $13,000 | -50.0% | 39,800 | -59.6% | 0.00% | – |
| Q2 2019 | $26,000 | -89.3% | 98,524 | -56.2% | 0.00% | – |
| Q1 2019 | $243,000 | -47.9% | 224,691 | -16.6% | 0.00% | – |
| Q4 2018 | $466,000 | -41.2% | 269,447 | +97.2% | 0.00% | – |
| Q3 2018 | $793,000 | +81.9% | 136,651 | +34.1% | 0.00% | – |
| Q2 2018 | $436,000 | +35.8% | 101,878 | +86.1% | 0.00% | – |
| Q1 2018 | $321,000 | +197.2% | 54,733 | +133.7% | 0.00% | – |
| Q4 2017 | $108,000 | -50.5% | 23,425 | -41.0% | 0.00% | – |
| Q3 2017 | $218,000 | -56.7% | 39,726 | -54.5% | 0.00% | – |
| Q2 2017 | $503,000 | +136.2% | 87,339 | +136.7% | 0.00% | – |
| Q1 2017 | $213,000 | -22.5% | 36,906 | -29.2% | 0.00% | – |
| Q4 2016 | $275,000 | +957.7% | 52,142 | +300.0% | 0.00% | – |
| Q3 2016 | $26,000 | 0.0% | 13,036 | +5.0% | 0.00% | – |
| Q2 2016 | $26,000 | -95.4% | 12,411 | -93.7% | 0.00% | -100.0% |
| Q4 2015 | $568,000 | -66.4% | 197,168 | -48.1% | 0.00% | -50.0% |
| Q3 2015 | $1,690,000 | +15.4% | 379,695 | +33.6% | 0.00% | +100.0% |
| Q2 2015 | $1,464,000 | – | 284,228 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
| Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
| Quilter Plc | 60,546 | $19,000 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
| MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
| BlackRock Inc. | 645,611 | $200,000 | 0.00% |
| Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |